Cover Image
Market Research Report

Global CRO Market, 2016

Published by Frost & Sullivan Product code 492746
Published Content info 289 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global CRO Market, 2016
Published: April 19, 2017 Content info: 289 Pages
Description

The Global CRO Market to Reach $64.58 Billion by 2021

The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting their business models towards a more collaborative business model and have started to look out for partners, giving rise to Bio analytics focused CROs.

The research study also addresses some of the major issues and challenges alongside providing information on the key unmet needs and emerging trends in the market. The report also outlines market drivers and restraints, market engineering measurements as well as R&D trends. Alongside the challenges and opportunities, a special focus is given on the emerging trends and their importance across the current and future market scenario. The report also highlights some of the major shifts occurring in the CRO and Pharma ecosystem with the emergence of several new and innovative CRO players in the market with a specific focus on niche segments, such as bioanalytics and HEOR amongst others.

Further to this, a detailed information will be provided on support services such as Central laboratory services, Bio analytics and Data management. The report covers the complete life cycle of CRO industry, starting from preclinical trials to post-marketing surveillance. One of the focus areas of this study would be bio analytics services, which is making a big impact in CRO industry. There is a major shift observed across the CRO landscape with several key pharma players now outsourcing their early drug development activities (pre-clinical and early phase research) to some of the leading CRO players in the market which was earlier handled by pharma companies themselves.

Some of the key questions being answered by this report include:

  • How will the contract research outsourcing help in drug development by saving time and cost for manufacturers?
  • What is the impact of the market growth in different regions?
  • Who are the dominant market participants in the CRO market and their market share contribution?
  • What are the key market trends observed toward expansion of contract research organizations in drug development across key therapeutic areas?
  • Do the products/services offered today meet customer needs or is additional development needed?
  • What are the key segments to look out for and what are the key trends in the market?

Table of Contents
Product Code: P94F-52

Table of Contents

1. EXECUTIVE SUMMARY

  • Key Findings
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions this Study will Answer
  • Market Engineering Measurements
  • Market Engineering Measurements (continued)
  • Trends for the CRO Market
  • Transformation of Industry Ecosystem
  • Pharmaceutical Outsourcing Value Chain
  • Transition from Small Molecules to Large Molecules
  • Biologics vs. Chemical Drugs
  • Key Technology Trends-BI Embedded in Clinical Trial Informatics on the Rise with Hybrid Business Models
  • Key Social Media Trend
  • Game-changing Companies
  • 8 Big Market Themes for CROs
  • CEO's Perspective
  • Key Companies to Watch
  • Key Companies to Watch (continued)
  • Key Companies to Watch (continued)
  • 3 Big Predictions

2. MARKET OVERVIEW

  • Market Segmentation
  • Global R&D Spending-Pharmaceutical Drug Development
  • Global R&D Market Landscape
  • Global Market Perspective
  • CRO Product Development and Commercialization
  • Global CRO Market Snapshot
  • Global CRO Market Snapshot by Region
  • Global CRO Market Attractiveness Matrix
  • Global CRO Revenue by Clinical Development Stage
  • Market Segmentation-Percent Revenue by Clinical Development Stage
  • Market Segmentation-Percent Share of Clinical Trials by Therapeutic Services
  • Market Segmentation-Percent Revenue Forecast by Therapeutic Area
  • Market Segmentation-Percent Revenue by Region
  • Global CRO Market-Key Trends and Impact on the Business
  • eClinical Solutions
  • eClinical Solutions-Applications and Technologies
  • Rise of Virtual Business Models

3. COMPETITIVE PLAYBOOK

  • New Market Opportunities
  • Critical Unmet Needs and Game-changing Strategies
  • Critical Unmet Needs and Game-changing Strategies (continued)
  • Global CRO Industry-Major Stake Holders
  • Global CRO Competitive Matrix
  • Merger, Acquisition, and Partnership Assessment
  • Merger, Acquisition, and Partnership Assessment (continued)
  • Merger, Acquisition, and Partnership Assessment (continued)
  • Merger, Acquisition, and Partnership Assessment (continued)
  • Merger, Acquisition, and Partnership Assessment (continued)

4. DRIVERS AND RESTRAINTS-TOTAL CRO MARKET

  • Global CRO Market Drivers
  • Global CRO Market Restraints

5. FORECASTS AND TRENDS-TOTAL CRO MARKET

  • Market Engineering Measurements
  • Market Engineering Measurements (continued)
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Percent Revenue Forecast by Region
  • Revenue Forecast by Region

6. COMPETITIVE ENVIRONMENT

  • Competitive Analysis-Market Share
  • Market Share Analysis
  • Competitive Environment
  • Competitive Analysis-Select Key Market Participants
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)
  • Competitive Analysis-Select Key Market Participants (continued)

7. CRO SEGMENT ANALYSIS-PRE-CLINICAL TRIALS SEGMENT

  • Pre-clinical Trials Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pre-clinical Trials Segment Metrics Analysis
  • Pre-clinical Trials Segment Metrics Analysis (continued)
  • Pre-clinical Trials Segment Key Trends

8. PHASE I TRIALS SEGMENT

  • Phase I Trials Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Phase I Trials Segment Metrics Analysis
  • Phase I Trials Segment Metrics Analysis (continued)
  • Phase I Trials Segment Key Trends

9. PHASE II TRIALS SEGMENT

  • Phase II Trials Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Phase II Trials Segment Metrics Analysis
  • Phase II Trials Segment Metrics Analysis (continued)
  • Phase II Trials Segment Key Trends

10. PHASE III TRIALS SEGMENT

  • Phase III Trials Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Phase III Trials Segment Metrics Analysis
  • Phase III Trials Segment Metrics Analysis (continued)
  • Phase III Trials Segment Key Trends

11. PHASE IV TRIALS SEGMENT

  • Phase IV Trials Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Phase IV Trials Segment-Revenue Forecast Discussion
  • Phase IV Trials Segment Metrics Analysis
  • Phase IV Trials Segment Metrics Analysis (continued)
  • Phase IV Trials Segment Key Trends

12. DATA MANAGEMENT SEGMENT

  • Data Management Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Data Management Segment Metrics Analysis
  • Data Management Segment Metrics Analysis (continued)
  • Data Management Segment Key Trends

13. BIOSTATISTICS SEGMENT

  • Biostatistics Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Biostatistics Segment Metrics Analysis
  • Biostatistics Segment Metrics Analysis (continued)
  • Biostatistics Segment Key Trends

14. PHARMACOVIGILANCE SEGMENT

  • Pharmacovigilance Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Pharmacovigilance Segment Metrics Analysis
  • Pharmacovigilance Segment Metrics Analysis (continued)
  • Pharmacovigilance Segment Key Trends

15. HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) SEGMENT

  • HEOR Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • HEOR Segment Metrics Analysis
  • HEOR Segment Metrics Analysis (continued)
  • HEOR Segment Key Trends

16. CENTRAL LABORATORY TESTING SEGMENT

  • Central Laboratory Testing Segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Central Laboratory Testing Segment Metrics Analysis
  • Central Laboratory Testing Segment Metrics Analysis (continued)

17. ANALYTICAL TESTING SERVICE SEGMENT

  • Bioanalytical and cGMP Testing Segments
  • Analytical Testing Services-Overview
  • Analytical Testing Services-Segmentation
  • Analytical Testing Services-Segmentation (continued)
  • Analytical Testing Services-Key Trends
  • Analytical Testing Services-Key Trends Explained
  • Analytical Testing Services-Key Trends Explained (continued)

18. ANALYTICAL TESTING SERVICES-CGMP TESTING SUB-SEGMENT

  • cGMP Testing Sub-segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • cGMP Testing Sub-segment Metrics Analysis
  • cGMP Testing Sub-segment Metrics Analysis (continued)
  • Percent Revenue by Type of Service

19. ANALYTICAL TESTING SERVICES-BIOANALYTICAL TESTING SUB-SEGMENT

  • Bioanalytical Testing Sub-segment Overview
  • Market Engineering Measurements
  • Revenue Forecast
  • Revenue Forecast Discussion
  • Bioanalytical Testing Sub-segment Metrics Analysis
  • Bioanalytical Testing Sub-segment Metrics Analysis (continued)
  • Percent Revenue by Type of Service

20. ANALYTICAL TESTING SERVICES SEGMENT-COMPETITIVE ENVIRONMENT

  • Analytical Testing Services Segment-Major Participants
  • Analytical Testing Services Segment-Market Share
  • Analytical Testing Services Segment-Market Share Analysis
  • Analytical Testing Services-Applications in Drug Discovery, Development and Manufacturing
  • Analytical Testing Services Segment-Competitive Environment
  • Competitive Analysis-Selected Key Market Participants
  • Competitive Analysis-Selected Key Market Participants (continued)
  • Competitive Analysis-Selected Key Market Participants (continued)
  • Competitive Analysis-Selected Key Market Participants (continued)
  • Competitive Analysis-Selected Key Market Participants (continued)
  • Competitive Analysis-Selected Key Market Participants (continued)

21. NORTH AMERICA CRO MARKET OVERVIEW

  • North America Breakdown
  • Percent Revenue by Clinical Development Stage
  • Percent Share of Clinical Trials by Therapeutic Services
  • Percent Revenue by Therapeutic Area
  • Revenue by Clinical Development Stage
  • Market Engineering Measurements
  • Revenue Forecast
  • Percent Revenue Forecast by Clinical Development Stage
  • Revenue Forecast Discussion

22. NORTH AMERICA SEGMENT ANALYSIS BY CLINICAL DEVELOPMENT STAGE

  • Pre-clinical and Phase I Trials Revenue Forecast
  • Phase II and Phase III Trials Revenue Forecast
  • Phase IV Trials and Pharmacovigilance Revenue Forecast
  • Biostatistics and Data Management Revenue Forecast
  • Bioanalytical and Central Laboratory Testing Revenue Forecast
  • HEOR Segment-Revenue Forecast
  • Market Share

23. EUROPE CRO MARKET OVERVIEW

  • Europe Breakdown
  • Percent Revenue by Clinical Development Stage
  • Percent Share of Clinical Trials by Therapeutic Services
  • Percent Revenue by Therapeutic Area
  • Revenue by Clinical Development Stage
  • Market Engineering Measurements
  • Revenue Forecast
  • Percent Revenue Forecast by Clinical Development Stage
  • Revenue Forecast Discussion

24. EUROPE SEGMENT ANALYSIS BY CLINICAL DEVELOPMENT STAGE

  • Pre-clinical and Phase I Trials Segment-Revenue Forecast
  • Phase II and Phase III Trials Segment-Revenue Forecast
  • Phase IV Trials and Pharmacovigilance Segment-Revenue Forecast
  • Biostatistics and Data Management Segment-Revenue Forecast
  • Bioanalytical and Central Laboratory Testing Segment-Revenue Forecast
  • HEOR Segment-Revenue Forecast
  • Market Share

25. APAC CRO MARKET OVERVIEW

  • APAC Breakdown
  • Percent Revenue by Clinical Development Stage
  • Percent Share of Clinical Trials by Therapeutic Services
  • Percent Revenue by Therapeutic Area
  • Revenue by Clinical Development Stage
  • Market Engineering Measurements
  • Revenue Forecast
  • Percent Revenue Forecast by Clinical Development Stage
  • Revenue Forecast Discussion

26. APAC SEGMENT ANALYSIS BY CLINICAL DEVELOPMENT STAGE

  • Pre-clinical and Phase I Trials Segment-Revenue Forecast
  • Phase II and Phase III Trials Segment-Revenue Forecast
  • Phase IV Trials and Pharmacovigilance Segment-Revenue Forecast
  • Biostatistics and Data Management Segment-Revenue Forecast
  • Bioanalytical and Central Laboratory Testing Segment-Revenue Forecast
  • HEOR Segment-Revenue Forecast
  • Market Share

27. ROW CRO MARKET OVERVIEW

  • ROW Breakdown
  • Percent Revenue by Clinical Development Stage
  • Percent Share of Clinical Trials by Therapeutic Services
  • Percent Revenue by Therapeutic Area
  • Revenue by Clinical Development Stage
  • Market Engineering Measurements
  • Revenue Forecast
  • Percent Revenue Forecast by Clinical Development Stage
  • Revenue Forecast Discussion

28. ROW SEGMENT ANALYSIS BY CLINICAL DEVELOPMENT STAGE

  • Pre-clinical and Phase I Trials Segment-Revenue Forecast
  • Phase II and Phase III Trials Segment-Revenue Forecast
  • Phase IV Trials and Pharmacovigilance Segment-Revenue Forecast
  • Biostatistics and Data Management Segment-Revenue Forecast
  • Bioanalytical and Central Laboratory Testing Segment-Revenue Forecast
  • HEOR Segment-Revenue Forecast
  • Market Share

29. GROWTH OPPORTUNITIES FOR THE GLOBAL CRO MARKET

  • Growth Opportunities for the Global CRO Market
  • Growth Opportunities for the Global CRO Market (continued)

30. THE LAST WORD

  • 3 Big Predictions
  • The Last Word-Discussion
  • Legal Disclaimer

31. APPENDIX

  • Global CRO Market-Drivers Explained
  • Global CRO Market-Restraints Explained
  • Global CRO Market-Restraints Explained (continued)
  • Market Engineering Methodology
  • Key Companies to Watch
  • Key Companies to Watch (continued)
  • Key Companies to Watch (continued)
  • Key Companies to Watch (continued)
  • Key Companies to Watch (continued)
  • Global CRO Market-Key Trends and Impact on the Business
  • Global CRO Market Trends Explained
  • Global CRO Market Trends Explained (continued)
  • Global CRO Market Trends Explained (continued)
  • Global CRO Market Trends Explained (continued)
Back to Top